BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6755558)

  • 1. Search for pharmaceutically interesting quinazoline derivatives: efforts and results (1969-1980).
    Johne S
    Prog Drug Res; 1982; 26():259-341. PubMed ID: 6755558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quinazoline derivatives in pharmaceutical research].
    Johne S
    Pharmazie; 1981 Sep; 36(9):583-96. PubMed ID: 6117883
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologically active quinazolones.
    Sinha S; Srivastava M
    Prog Drug Res; 1994; 43():143-238. PubMed ID: 7855250
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of quinazolines: Pharmacological significance and recent developments.
    Alagarsamy V; Chitra K; Saravanan G; Solomon VR; Sulthana MT; Narendhar B
    Eur J Med Chem; 2018 May; 151():628-685. PubMed ID: 29656203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal applications of indole derivatives.
    Sugden JK; Yoloye TO
    Pharm Acta Helv; 1978; 53(3-4):65-92. PubMed ID: 30094
    [No Abstract]   [Full Text] [Related]  

  • 6. Folate antagonists. 12. Antimalarial and antibacterial effects of 2,4-diamino-6-[(aralkyl and alicyclid)thio-, sulfinyl-, and sulfonyl]quinazolines.
    Elslager EF; Davoll J; Jacob P; Johnson AM; Johnson J; Werbel LM
    J Med Chem; 1978 Jul; 21(7):639-43. PubMed ID: 97382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity.
    Elslager EF; Clarke J; Werbel LM; Worth DF; Davoll J
    J Med Chem; 1972 Aug; 15(8):827-36. PubMed ID: 4625530
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinazolines. 12. 1,3-Diaminobenzo(f)quinazolines containing long-chain alkyl or chloro substituents on the central ring. Synthesis and biological evaluation as candidate antifolate and antimalarial agents.
    Rosowsky A; Huang PC; Papathanasopoulos N; Modest EJ
    J Med Chem; 1974 Nov; 17(11):1217-22. PubMed ID: 4606974
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of SR 720-22.
    Belair E; Kaiser F; Van Denburg B; Borelli A; Lawlor R; Panasevich R; Yelnosky J
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):71-87. PubMed ID: 4982115
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of 5-substituted quinazolines as potential antimalarial agents.
    Ashton WT; Hynes JB
    J Med Chem; 1973 Nov; 16(11):1233-7. PubMed ID: 4583883
    [No Abstract]   [Full Text] [Related]  

  • 11. An Explicative Review on the Progress of Quinazoline Scaffold as Bioactive Agents in the Past Decade.
    Jain N; Goel T; Thakar S; Jadhav M; Bansode D
    Med Chem; 2023; 19(3):211-245. PubMed ID: 35670342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
    Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo.
    Bertino JR; Sawicki WL; Moroson BA; Cashmore AR; Elslager EF
    Biochem Pharmacol; 1979 Jun; 28(12):1983-7. PubMed ID: 454469
    [No Abstract]   [Full Text] [Related]  

  • 14. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quinazoline antifolate as inhibitor of folate metabolism in mouse L-cells.
    Sikora E; Grzelakowska-Sztabert B
    Acta Biochim Pol; 1983; 30(2):193-201. PubMed ID: 6868908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate antagonists. 13. 2,4-Diamino-6-](alpha,alpha,alpha-trifluoro-m-tolyl)thio]quinazoline and related 2,4-diamino-6-[(phenyl- and naphthyl)thio]quinazolines, a unique class of antimetabolites with extraordinary antimalarial and antibacterial effects.
    Elslager EF; Jacob P; Johnson J; Werbel LM; Worth DF; Rane L
    J Med Chem; 1978 Oct; 21(10):1059-70. PubMed ID: 102792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
    Elslager EF; Hutt MP; Jacob P; Johnson J; Temporelli B; Werbel LM; Worth DF; Rane L
    J Med Chem; 1979 Oct; 22(10):1247-57. PubMed ID: 117107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate antagonists. 9. 2,4-Diamino-6-((aralkyl)alkylamino)quinazolines, a potent class of antimetabolites with prodigious antimalarial effects.
    Elslager EF; Bird OD; Clarke J; Perricone SC; Worth DF
    J Med Chem; 1972 Nov; 15(11):1138-46. PubMed ID: 4631920
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of some bis(2,4-diaminopyrimidines) and bis(2,4-diaminoquinazolines) as potential antimalarial agents.
    Hynes JB; Gratz RF; Ashton WT
    J Med Chem; 1972 Dec; 15(12):1332-3. PubMed ID: 4629015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in the field of drug development. 17].
    Délenk-Heydenreich K; Henkler G; Keller U; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1984 Nov; 39(11):725-37. PubMed ID: 6085168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.